Suppr超能文献

微血管密度在子宫内膜癌中的独立预后意义。

Independent prognostic importance of microvessel density in endometrial carcinoma.

作者信息

Salvesen H B, Iversen O E, Akslen L A

机构信息

Department of Gynaecology and Obstetrics, The Gade Institute, Haukeland University Hospital, Bergen, Norway.

出版信息

Br J Cancer. 1998 Apr;77(7):1140-4. doi: 10.1038/bjc.1998.189.

Abstract

Angiogenesis is thought to be an important factor for tumour growth and metastatic spread, and microvessel counts may provide useful prognostic information for several tumour types. To investigate the prognostic impact of angiogenesis in endometrial carcinoma patients, the intratumour microvessel density, which was determined immunohistochemically, has been related to survival. Sixty patients with endometrial carcinoma with long (median 19 years) and complete follow-up have been studied. Patients with increased mean microvessel density (MVDmean > 68 mm2) had a significantly shorter 5-year survival compared with the rest (57% vs 90%, P = 0.004). In multivariate survival analyses, MVDmean had an independent prognostic impact (P = 0.03) when FIGO stage, histological type, histological grade as well as nuclear p53 protein expression was adjusted for. These findings indicate that intratumour microvessel density may contribute additional prognostic information to that obtained from the known risk factors and may be helpful in identifying endometrial carcinoma patients at high risk for disease progression.

摘要

血管生成被认为是肿瘤生长和转移扩散的一个重要因素,微血管计数可能为几种肿瘤类型提供有用的预后信息。为了研究血管生成对子宫内膜癌患者的预后影响,通过免疫组织化学测定的肿瘤内微血管密度与生存率相关。对60例子宫内膜癌患者进行了长期(中位时间19年)且完整的随访研究。平均微血管密度增加(MVDmean > 68 mm2)的患者与其余患者相比,5年生存率显著缩短(57% 对 90%,P = 0.004)。在多因素生存分析中,在对国际妇产科联盟(FIGO)分期、组织学类型、组织学分级以及核p53蛋白表达进行校正后,MVDmean具有独立的预后影响(P = 0.03)。这些发现表明,肿瘤内微血管密度可能为从已知风险因素中获得的信息提供额外的预后信息,并且可能有助于识别疾病进展风险高的子宫内膜癌患者。

相似文献

4
Angiogenesis in endometrial carcinoma.子宫内膜癌中的血管生成
Cancer. 1997 Aug 15;80(4):741-7. doi: 10.1002/(sici)1097-0142(19970815)80:4<741::aid-cncr13>3.0.co;2-t.

引用本文的文献

2
Recent Advances in Endometrial Cancer.子宫内膜癌的最新进展
F1000Res. 2017 Jan 27;6:81. doi: 10.12688/f1000research.10020.1. eCollection 2017.
3
Promising novel therapies for the treatment of endometrial cancer.有前景的新型疗法治疗子宫内膜癌。
Gynecol Oncol. 2010 Feb;116(2):187-94. doi: 10.1016/j.ygyno.2009.10.041. Epub 2009 Nov 10.
7
Vasculogenic mimicry and tumor angiogenesis.血管生成拟态与肿瘤血管生成
Am J Pathol. 2000 Feb;156(2):361-81. doi: 10.1016/S0002-9440(10)64739-6.

本文引用的文献

4
Endometrial carcinoma.子宫内膜癌
N Engl J Med. 1996 Aug 29;335(9):640-9. doi: 10.1056/NEJM199608293350907.
5
Angiogenesis factor in endometrial carcinoma: a new prognostic indicator?子宫内膜癌中的血管生成因子:一种新的预后指标?
Am J Obstet Gynecol. 1996 Jun;174(6):1879-82; discussion 1882-4. doi: 10.1016/s0002-9378(96)70224-7.
7
p53 as a prognostic indicator in endometrial cancer.p53作为子宫内膜癌的预后指标
Gynecol Oncol. 1996 May;61(2):245-8. doi: 10.1006/gyno.1996.0133.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验